Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
In this study we will try to improve the outcome for children with stage II disease. It is hoped that we will be able to show that with early intervention correct early diagnosis the survival of these children is greatly improved. The collection of data in this observational study will allow us to show this improvement, by analysis of stage, treatment and outcome.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| OBSERVATIONAL | Other | We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of cases with retinoblastoma in each participating hospital. | Evaluation of the number of cases registered . | 10 years |
| Number of cases with stage 2 disease | Evaluation of the number of cases registered with stage 2 disease. | 10 years |
| Feasibility of these therapeutic recommendations in an African setting | Evaluate the application of these therapeutic recommendations | 10 years |
| Evaluating the treatment given. | Comparison of treatment given and recommended treatment. | 10 years |
| follow up | analysis of the number of children alive or dead after treatment | 10 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
all children presenting at participating units who can be treated
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| KARIM Mr ASSANI, Dr. | Contact | 00243971359726 | drassanik@gmail.com | |
| BRENDA Ms MALLON, MSc | Contact | 0033142115411 | brenda.mallon@gustaveroussy.fr |
| Name | Affiliation | Role |
|---|---|---|
| FOUSSEYNI Mr TRAORE, Dr; | AMCC AND GFAOP | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Yalgado Ouedraogo | Recruiting | Ouagadougou | 03 BP 7022 | Burkina Faso |
Not provided
| ID | Term |
|---|---|
| D012175 | Retinoblastoma |
| ID | Term |
|---|---|
| D018302 | Neoplasms, Neuroepithelial |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| ID | Term |
|---|---|
| D057832 | Watchful Waiting |
| ID | Term |
|---|---|
| D017063 | Outcome Assessment, Health Care |
| D010043 | Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
| CHU de Treichville à ABIDJAN | Recruiting | Abidjan | Côte d’Ivoire |
|
| CUK (Cliniques Universitaires de Kinshasa) | Recruiting | Kinshasa | Kinshasa City | BP 12 KIN XI | Democratic Republic of the Congo |
|
| Cliniques Universitaires de Lubumbashi (CUL) | Recruiting | Lubumbashi | BP 1825 | Democratic Republic of the Congo |
|
| HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona | Recruiting | Antananarivo | Ampefiloha | BP 4150 | Madagascar |
|
| CHU Gabriel Touré (HGT) | Recruiting | Bamako | Mali |
|
| Hôpital Aristide Le Dantec, | Recruiting | Dakar | BP 3001 | Senegal |
|
| D009369 | Neoplasms |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009380 | Neoplasms, Nerve Tissue |
| D019572 | Retinal Neoplasms |
| D005134 | Eye Neoplasms |
| D009371 | Neoplasms by Site |
| D015785 | Eye Diseases, Hereditary |
| D005128 | Eye Diseases |
| D012164 | Retinal Diseases |